Citation Impact
Citing Papers
LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor
2009
5-Hydroxytryptamine3 (5-HT3) Receptors Mediate Spinal 5-HT Antinociception: An Antisense Approach
2001
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
Involvement of 5-HT1C-receptors in drug-induced penile erections in rats
1990
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 StandoutNobel
Evidence that RU 24969‐induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5‐HT1B receptor
1993
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
2004
Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: A comparative study with dorsal raphe neurons
1988
Centrally active 5-HT receptor agonists and antagonists
1992
Drug Addiction, Dysregulation of Reward, and Allostasis
2001 Standout
Imidazolones in Diastereoselective Cyclization Reactions and CuII‐Catalysed Cross‐Coupling Reactions
2009 StandoutNobel
Descending control of pain
2002 Standout
Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat
1990
Mechanisms of action of atypical antipsychotic drugs
1991
Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors
2000
Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor
1988
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Autoradiographic localization of dopamine D1 and D2 receptors in the brain of several mammalian species
1990
The Role of Serotonin in Schizophrenia
1988
Noradrenergic mediation of spinal antinociception by 5-hydroxytryptamine: characterization of receptor subtypes
1992
The serotonin 5-HT1D receptor: A progress review
1990
Network pharmacology: the next paradigm in drug discovery
2008 Standout
5-HT2A receptor or α1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex
1999
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine?s actions?
2004
Psychedelics
2016 Standout
Endothelin‐1 (ET‐1)‐induced contraction in rat isolated trachea: involvement of ETa and ETB receptors and multiple signal transduction systems
1993
Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia
1989
Heterogenous effects of serotonin in the dorsal horn of rat: the involvement of 5-HT1 receptor subtypes
1988
Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: Potential treatment of extrapyramidal side effects
1993 StandoutNobel
Neuroleptics increase C-FOS expression in the forebrain: Contrasting effects of haloperidol and clozapine
1992
The Role of Serotonin in Antipsychotic Drug Action
1999
Functional Imaging of Neural Responses to Expectancy and Experience of Monetary Gains and Losses
2001 StandoutNobel
Deep-sea natural products
2008
Network interactions in schizophrenia — therapeutic implications
2000 StandoutNobel
The amygdala: vigilance and emotion
2000 Standout
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
1998 Standout
Staining in the brain of Pachymorpha sexguttata mediated by an antibody against a Drosophila clock-gene product: labeling of cells with possible importance for the beetle's circadian rhythms
1996 StandoutNobel
Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia
1994
Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic
1997
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Dopamine functions in appetitive and defensive behaviours
1992
Receptor subtype-specific dopaminergic agents and conditioned behavior
1989
Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393
1987 StandoutNobel
Differential effects of novel ligands for 5-HT receptor subtypes on nonopioid defensive analgesia in male mice
1991
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The 5‐HT1B Receptors
1990
Behavioural evidence for functional interactions between 5‐HT‐receptor subtypes in rats and mice
1990
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Metal‐Catalyzed Enantioselective Allylation in Asymmetric Synthesis
2007 Standout
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000 Standout
Amino acid derived 1,4‐dialkyl substituted imidazolones
2010 StandoutNobel
Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia
1998 StandoutNobel
5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by μ-opiate receptor activation
1998
Phosphorylation and Desensitization of Human Endothelin A and B Receptors
1997 StandoutNobel
The Mechanism of Action of Novel Antipsychotic Drugs
1991
Effect of serotonergic agonists in the nucleus accumbens on d-amphetamine-stimulated locomotion
1992
A review of central 5-HT receptors and their function
1999 Standout
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
Characterization of the head-twitch response induced by hallucinogens in mice
2013
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
1991 Standout
Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
1990
The role of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors in modulating spinal nociceptive transmission in normal and carrageenan-injected rats
2001
Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
1987
Autoradiography of serotonin receptor subtypes in the central nervous system
1991
Relating protein pharmacology by ligand chemistry
2007 Standout
5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra
1988
Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice
2011
d-amphetamine and l-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the α2C-adrenergic receptor subtype
1998 StandoutNobel
Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors
1991
Substituted 3-(2-benzoxazyl)-benzimidazol-2-(1H)-ones: A new class of GABAA brain receptor ligands
2000
Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys
1992
Molecular cloning of 5-hydroxytryptamine (5-HT) type 1 receptor genes from the Japanese puffer fish, Fugu rubripes
1997 StandoutNobel
Effects of intra-amygdalar Thyrotropin Releasing Hormone (TRH) and its antagonism by atropine and benzodiazepines during stress ulcer formation in rats
1990
Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior
1991
Diagnosing the decline in pharmaceutical R&D efficiency
2012 Standout
Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
1996 StandoutNobel
The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats
1986 StandoutNobel
Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia
1997
Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons
1987
Chemistry of Polyvalent Iodine
2008 Standout
Sexually differentiated actions of 3-PPP enantiomers on prolactin secretion
1986 StandoutNobel
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Serotonin–Glutamate Interactions A New Target for Antipsychotic Drugs
1999
Serotonin and the Mammalian Circadian System: I. In Vitro Phase Shifts by Serotonergic Agonists and Antagonists
1993
Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene.
1990
π-Face selective azaspirocyclization of ω-(methoxyphenyl)-N-methoxyalkylamides
2003
Distribution of D2 dopamine receptor mRNA in rat brain.
1989
Aerobic Copper-Catalyzed Organic Reactions
2013 Standout
Enantioselective Allylation of Nitro Group-Stabilized Carbanions Catalyzed by Chiral Crown Ether Phosphine−Palladium Complexes
1996
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm
1987 StandoutNobel
Perspectives on the Discovery of Central Monoaminergic Neurotransmission
1987 StandoutNobel
Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity
1985 StandoutNobel
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
Advances in Synthetic Applications of Hypervalent Iodine Compounds
2016 Standout
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
2001 Standout
Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerations
1985 StandoutNobel
Copper-Catalyzed Aerobic [3+2]-Annulation of N-Alkenyl Amidines
2012
Neuroleptic-induced acute dyskinesias in rhesus monkeys
1981
Pharmacogenetic Evidence for the Involvement of 5-Hydroxytryptamine (Serotonin)-1B Receptors in the Mediation of Morphine Antinociceptive Sensitivity
1999
An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system
1985 StandoutNobel
Dopamine Receptors: From Structure to Function
1998 Standout
Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: Discrepancies between and observations
1985 StandoutNobel
Hallucinogens
2004 Standout
Works of Robert Neale being referenced
Synthesis, opioid receptor binding profile, and antinociceptive activity of 1-azaspiro[4.5]decan-10-yl amides
1989
Anxiolytic properties of certain annelated [1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-ones
1991
Sesquiterpene-Derived Metabolites from the Deep Water Marine Sponge Poecillastra sollasi
1993
Characterization of rat lung endothelin receptor subtypes which are coupled to phosphoinositide hydrolysis.
1992
Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist
1987
Antagonism of l-5-hydroxytryptophan-induced head twitching in rats by lisuride: A mixed 5-hydroxytryptamine agonist-antagonist?
1985
Neuroleptic-induced acute dyskinesias in squirrel monkeys: Correlation with propensity to cause extrapyramidal side effects
1980
Avoidance and ICSS behavioral models dissociate TL-99 and 3-PPP from dopamine receptor antagonists
1983
Differential behavioral effects of sulpiride in the rat and squirrel monkey
1978
Typical and atypical antipsychotic occupancy of D2 and S2 receptors: An autoradiographic analysis in rat brain
1986
Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance.
1986
Effects of dopamine agonists, catecholamine depletors, and cholinergic and GABAergic drugs on acute dyskinesias in squirrel monkeys
1983